Existing data suggest that immune reactions reduce the lifespan of animal-derived heart valves implanted in cardiac patients. An EU-funded project discovered how to overcome this limitation, to produce valves with improved biocompatibility and novel immunological strategies that will benefit younger patients in particular. (Source: EUROPA - Research Information Centre)
from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2zSuQUw
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.